An estimated 5.5 million Americans live with Alzheimer's disease, a type of dementia that causes problems with memory, thinking and behavior. Although treatments can slow the worsening of symptoms, scientists are still working to better understand the neurodegenerative disease so that curative and preventative medicines can be developed. Show More Summary
(The Optical Society) A new imaging system that offers a better way to monitor the brain changes indicative of Alzheimer's in mouse models of the disease could help speed new drug development.
Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study published in the journal Nature Medicine, a team of researchers...Show More Summary
Some 400 people walked in solidarity to raise money and awareness for Alzheimer’s disease and dementia at the Alzheimer’s walk in Laguna Niguel on Saturday, Oct. 14. Walk4ALZ, the two-mile walk hosted by Alzheimer’s Orange County, raised $40,000 that will go to countywide services that help people with Alzheimer’s disease and other forms of dementia. […]
It has been observed that Alzheimer's disease and osteoporosis appear to be correlated to a larger degree than one would expect simply because both emerge, after a long chain of cause and effect, from the root causes of aging. That they are correlated in this way suggests that they share in common some parts of the middle of that long chain. Show More Summary
(National Research University Higher School of Economics) Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years. This problem...Show More Summary
(McGill University) Researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer's disease. In the brain tissue of Alzheimer's patients, the RNAs that encode synaptic proteins are degraded more rapidly than in healthy brain cells, the researchers found. Show More Summary
A research team is assessing how a person's genetic profile affects his body. The results could help show how individual genetic differences contribute to disease and guide treatments for heritable disorders such as Alzheimer's, high cholesterol or Type 1 diabetes.
A new study looked at the metabolic changes in the brains of menopausal and perimenopausal women and found potential triggers for Alzheimer's disease.
Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer's disease, a team of scientists has shown in new research.
Following up his Oscar nominated documentary chronicling the late Glen Campbell’s fight against Alzheimers Disease, director James Keach tackles the inspirational story of Augie Nieto who is often referred to as the Steve Jobs of the fitness industry. Show More Summary
(Weill Cornell Medicine) Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer's disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.
While memory loss is an early symptom of Alzheimer's disease, its presence doesn't mean a person will develop dementia. A new study has found a clinically useful way to predict who won't develop Alzheimer's disease, based on patients' awareness of their memory problems.
(Centre for Addiction and Mental Health) While memory loss is an early symptom of Alzheimer's disease, its presence doesn't mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to predict who won't develop Alzheimer's disease, based on patients' awareness of their memory problems.
(University of California - Irvine) A proposal to humanize several mouse genes for research into Alzheimer's disease has spurred the National Institute on Aging to award $11.35 million to the University of California, Irvine.
Scientists drilling down to the molecular roots of Alzheimer's disease have encountered a good news/bad news scenario. A major player is a gene called TREM2, mutations of which can substantially raise a person's risk of the disease.Show More Summary
Scientists drilling down to the molecular roots of Alzheimer's disease have encountered a good news/bad news scenario. The bad news is that in the early stages of the disease, high-risk TREM2 variants can hobble the immune system's ability to protect the brain from amyloid beta. Show More Summary
Indiana University has been awarded a one-year, $7.6 million grant from the National Institute on Aging (NIA) to establish a network of sites to study early-onset Alzheimer's disease.
(Washington University School of Medicine) Scientists studying the molecular roots of Alzheimer's disease have encountered a good news/bad news scenario. The bad news is that in the early stages of the disease, high-risk TREM2 variants can hobble the immune system's ability to protect the brain from amyloid beta. Show More Summary
Learn more about tactile hallucinations and its symptoms. Including more on causes such as Alzheimer’s disease, Lewy body dementia, and delirium tremens.